B

Esmeralda García-Torralba1, Lorenzo Galluzzi2, Aitziber Buqué2

  • 1Cancer Signaling and Microenvironment Program, Fox Chase Cancer Center, Philadelphia, PA, USA; Department of Medical Oncology, Hospital Universitario Morales Meseguer, Murcia, Spain; Department of Medicine, Medical School, University of Murcia, Murcia, Spain; IMIB-Arrixaca, Murcia, Spain.

Trends in cancer
|October 1, 2024
PubMed
概括

激活的Fc受体样4 (FCRL4) B细胞在乳腺癌和其他瘤中被发现. 这种非典型的B细胞群与癌症患者的总体存活率更好有关.